Jose F. Rodríguez-Orengo

Jose F. Rodríguez-Orengo, PHD

Professor of Biochemistry at the University of Puerto Rico
CEO & CSO at FDI Clinical Research

University of Puerto Rico, School of Medicine

Dr. Jose F. Rodriguez-Orengo is Professor at the Department of Biochemistry, School of Medicine at the University of Puerto Rico and has more than 25 years of experience in higher education and scientific research with more than 75 peer-reviewed articles (basic, clinical, public health). He is the leader of the student activities of the Puerto Rico IDeA Network for Biomedical Research. Dr. Rodriguez-Orengo is CEO and CSO at FDI Clinical Research, a Clinical Research Organization in San Juan Puerto Rico where Phase 1 to Phase 3 are performed under FDA guidance. He is also Senior Consultant for the Puerto Rico Science Technology and Research Trust and Acting Director of the PR Public Health Trust. He was Executive Director at the Puerto Rico Institute of Forensic Sciences where he completed a radical transformation using lean-six-sigma approach to increase productivity and improve the quality of the processes. He was Acting Chancellor at the UPR-Medical Sciences Campus. With a research group of UPR-Medical Sciences Campus’ Professors, he is one of the founders of MBQ Pharma, the first Pharmaceutical Company developing anticancer products patented by the UPR. He was awarded in 2019 the Osvaldo Ramirez Award, the highest distinction for a chemist in Puerto Rico. He has the vision of integration and collaboration among different entities towards a common goal of promoting Puerto Rico as a premier site for clinical research.